PQ Corporation Recalls Epsom Salt Bags Due to High Iron Levels
PQ Corporation is recalling 50 lb bags of Epsom Salt because iron levels exceeded USP limits. The product was distributed in Kentucky.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which by definition is unlikely to cause adverse health consequences, fitting the 'Low' severity criteria for minor issues.
Plain-English summary
PQ Corporation is recalling 41,650 lbs (833 bags) of Epsom Salt (Magnesium Sulfate Heptahydrate, USP) in 50 lb multi-wall bags. The recall is due to failed impurities and degradation specifications, specifically because the level of iron exceeds the limit set by the USP monograph (USP limit is NMT 0.5 ug/g).
The affected product is Lot # U150511 with an expiration date of 05/18. The product was distributed in Kentucky. The FDA has classified this recall as Class III, indicating that use of or exposure to the violative product is not likely to cause adverse health consequences.
Consumers who have this product should stop using it and contact PQ Corporation for further instructions or a refund.
The recalled product
- Product
- EPSOM SALT(Magnesium Sulfate Heptahydrate, USP), 50 lb multi-wall bag, Rx only, Manufactured by PQ Corporation, P.O. Box 840, Valley Forge, Pennsylvania USA 19482.
- Manufacturer
- PQ Corporation
- Category
- Drug — Pharmaceutical Ingredient
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # U150511
- Exp. 05/18
Distribution
Distributed in 1 state:
Related recalls
Same hazard · impurity
See all →- ModerateAjanta Pharma Recalls Fluphenazine Hydrochloride Tablets Due to Impurity Failure
FDA (Drugs) · 2026-09-16
- ModerateHikma Recalls Ramipril Capsules Due to Process Impurity
FDA (Drugs) · 2026-09-02
- ModerateMedline Remedy Specialized Silicone Cream Recalled for Elevated Formaldehyde Levels
FDA (Drugs) · 2026-07-15
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- HighDuloxetine 60mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17
Similar recalls
- LowMorton Sodium Chloride USP Recalled for Slightly High Bromide Levels
FDA (Drugs) · 2012-08-29
- LowHospira Recalls Magnesium Sulfate Injection Due to pH Failures
FDA (Drugs) · 2016-05-25
- ModerateDoctor Teal's Epsom Salt Recalled for Improper Storage Conditions
FDA (Drugs) · 2022-08-31
- HighFood-Grade Salt Products Recalled for Foreign Material Contamination
FDA (Food) · 2024-12-25
- SevereLosartan Potassium Tablets Recalled Due to Impurity Presence
FDA (Drugs) · 2019-05-29
- CriticalFresenius Kabi Recalls Magnesium Sulfate Injection Due to Glass Particulates
FDA (Drugs) · 2013-09-04